Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease.

Thomas EbertNicolas LinderAlexander SchaudinnHarald BusseJoachim BergerRalf LichtinghagenVolker KeimJohannes WiegandThomas Karlas

Published in: Endocrine (2017)

Fetuin B is independently and negatively associated with non-invasive markers of liver fibrosis and PNPLA3 status in NAFLD patients but does not show a correlation with the hepatic lipid content. Future studies need to elucidate the pathophysiological significance of fetuin B in NAFLD and its potential value as predictor for disease severity.

Keyphrases

liver fibrosis
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes